Add Papers Marked0
Paper checked off!

Marked works

Viewed0

Viewed works

Shopping Cart0
Paper added to shopping cart!

Shopping Cart

Register Now

internet library
Atlants.lv library
FAQ
4,49 € Add to cart
Add to Wish List
Want cheaper?
ID number:866464
 
Evaluation:
Published: 24.11.2003.
Language: English
Level: Secondary school
Literature: n/a
References: Not used
Extract

Pfizer's establishment of co-development and marketing agreements reduce the time and money Pfizer spends on bringing a product to market, with the partner doing the early stage work prior to Pfizer's involvement. Shorter development times are a clear advantage in revenues terms.
Pfizer is making continual efforts to increase the efficiency of its R&D operations. The introduction of robotic high-speed synthesis technology has had a significant effect on the company's ability to create and modify new molecules. Pfizer has also pioneered new clinical testing technologies, utilized in its early development programs.
Pfizer's global presence means that newer products, which have only been launched in a relatively small number of markets to date, can be exposed to a much larger audience eventually, and Pfizer's ability to do this will greatly enhance the prospects of these drugs.
With its recognized marketing strength, Pfizer is likely to be considered a favored marketing partner for smaller companies who have exciting products in their pipelines, and Pfizer will be in a strong position to negotiate agreements which offer high financial rewards.

Load more similar papers

Atlants

Choose Authorization Method

Email & Password

Email & Password

Wrong e-mail adress or password!
Log In

Forgot your password?

Draugiem.pase
Facebook

Not registered yet?

Register and redeem free papers!

To receive free papers from Atlants.com it is necessary to register. It's quick and will only take a few seconds.

If you have already registered, simply to access the free content.

Cancel Register